Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
CMV: early-phase trial registry
3 of 8 indexed CMV trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 3 currently recruiting · #2,176 of 28,707 conditions by registered trial count
CMV: 8 US clinical trials tracked, 3 recruiting.
CMV is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Meridian Bioscience, running 1 of these trials.
Enrollment posture brief
Registry condition cmv
OPEN 3 | RECR 38% | LATE 1 | EARLY 4 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute-graft-versus-host Disease (38% recruiting · 8 trials)
CMV lists 3 open slots (38% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for CMV on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
CMV is recruiting below its size-band peers.
3 of 8 indexed trials (37.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of CMV trials is spread across many organizations.
Meridian Bioscience accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Most CMV trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 8 trials that report a genuine target (sentinel values excluded). 5 of those (62.5%) plan for fewer than 100 participants.
-
CMV splits between interventional and observational designs.
5 interventional and 3 observational studies make up this index (62.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01011712
CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT
University of California, Irvine
NCT06453460
CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients
University of Minnesota
NCT07096453
CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients
Vanderbilt University Medical Center
NCT03924219
De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients
Virginia Commonwealth University
NCT06001320
Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants
Albert Park
NCT03107871
Detection of Cytomegalovirus Virus in Neonates
Meridian Bioscience
NCT03251261
Cytotoxic T Cells to Prevent Virus Infections
Children's National Research Institute
NCT01923766
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on CMV records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on CMV trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this CMV page
8 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 CMV trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Meridian Bioscience sponsors the most CMV trials on record, review their full trial history before evaluating a specific study. See Meridian Bioscience's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This CMV condition card totals 8 registered trials; most-linked intervention illumigene CMV assay, illumipro-10; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.